SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-271739
Filing Date
2020-10-19
Accepted
2020-10-19 09:23:02
Documents
16
Period of Report
2020-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d79654d8k.htm   iXBRL 8-K 51866
2 EX-2.1 d79654dex21.htm EX-2.1 537427
3 EX-4.1 d79654dex41.htm EX-4.1 25983
4 EX-99.1 d79654dex991.htm EX-99.1 15580
8 GRAPHIC g79654g1018023233819.jpg GRAPHIC 8440
  Complete submission text file 0001193125-20-271739.txt   910533

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bstc-20201019.xsd EX-101.SCH 3070
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bstc-20201019_lab.xml EX-101.LAB 18139
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bstc-20201019_pre.xml EX-101.PRE 11408
9 EXTRACTED XBRL INSTANCE DOCUMENT d79654d8k_htm.xml XML 3421
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19879 | Film No.: 201245391
SIC: 2834 Pharmaceutical Preparations